Sign in

CIK 0001783183

  • Non-accelerated filer
  • Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
824151574
Phone
+1 877-742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 4 Open-market sale 10% owner sold 710,000 shares at $43.75 ($31,062,500)
  2. 4 Open-market sale Director sold 55,000 shares at an average $47.58 ($2,617,090)
  3. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $45.88 ($665,290)
  4. 4 Open-market sale Director sold 70,000 shares at an average $46.49 ($3,254,612)
  5. 5 Insider Annual Insider Trading Report
  6. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $39.89 ($578,441)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Director sold 40,000 shares at an average $35.70 ($1,428,038)
  11. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $33.61 ($487,275)
  12. 4 Open-market sale Director sold 79,658 shares at an average $43.42 ($3,458,896)
  13. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $44.74 ($648,688)
  14. 4 Open-market sale Director sold 30,342 shares at an average $41.30 ($1,253,198)
  15. 4 Open-market sale Chief Operating Officer sold 14,500 shares at $36.83 ($534,026)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Other disposition 10% owner disposed of 1,456,854 shares (other)

Page 10 of 12 · 224 filings